What is the news?
PharmEasy’s parent company API Holdings has signed final paperwork acquiring a 66.1 percent ownership in the Thyrocare Technologies Pvt Ltd from Dr. A Velumani and affiliates, for a price of Rs 1,300 each share, totaling Rs. 4.546 Cr. The acquisition is subject to regulatory and other customary approvals required.
Further information
“We are thrilled to be collaborating with Thyrocare,” stated Siddharth Shah, CEO of API Holdings. We deliver a world-class diagnostic customer experience, rivaling our pharmaceutical experience with technological leverage and creating Thyrocare in a large-scale and truly pan-Indian presence. Our goal is to offer all ambulatory health goods and services within 24 hours to every Indian.”
Recent Posts
PERT and CPM Project Management Techniques: Their Differences and How to Use Them Together
Table of Content Introduction to PERT and CPM PERT: Program Evaluation and Review Technique CPM:…
Project Management Basics
Project Management Definition –“PM is planning, organizing, directing, and controlling of company resources for a…
Different Agile Frameworks
Here are 7 Different Agile Frameworks which are used by different IT teams for Development.…
Comparison between AGI (Artificial General Intelligence) and AI (Artificial Intelligence)
Introduction to Artificial Intelligence Definition of artificial intelligence (AI) Evolution and applications of AI in…
Key Data Science Trends in 2024
Introduction to Data Science Trends What is data science? Importance of staying updated on trends…
Can New AI Development Platforms Supercharge Your Projects?
Can New AI Development Platforms Supercharge Your Projects? From revolutionizing industries to transforming our daily…